Mfazo Hove was diagnosed with acute anterior uveitis, followed by cataracts, and feared he could ‘lose (his) sight’.

Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique water-free EyeSol® drug category, today announced that the U.S. Food and Drug ...

The US Food and Drug Administration (FDA) has cleared Novaliq’s Investigational New Drug (IND) application for NOV05, enabling the initiation of the EYETAC phase II clinical trial ( NCT07285070) in ...

The FDA cleared an investigational new drug application to advance NOV05 in a phase 2 clinical trial in noninfectious ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A 29-year-old woman was referred to Tufts Medical Center ...

NICKI Guy was living the dream on a beautiful Caribbean island with her husband and young son when, peering into the mirror, ...

The report on Uveitis clinical trials highlights opportunities in understanding trial count, enrollment trends, and successful trial regions. It aids strategic investment decisions by identifying key ...

Difluprednate ophthalmic emulsion is indicated for the treatment of inflammation and pain associated with ocular surgery and also indicated for the treatment of endogenous anterior uveitis.

The Monongalia County Commission on Wednesday approved a resolution authorizing participation in a master lease-sublease agreement in support of Trinity Christian School. The agreement will allow the ...

Alembic Pharmaceuticals Ltd received final approval from the USFDA for its generic Difluprednate ophthalmic emulsion, used to ...

Orange, Calif.-based UCI Health has opened an outpatient center in Brea, Calif.  The Brea Outpatient Center will expand patient access to ophthalmologists from the UCI Health Gavin Herbert Eye ...

Alembic Pharmaceuticals said it has received final US FDA approval for its Difluprednate ophthalmic emulsion, expanding its ...